Clinical Trial Update: Belimumab in Patients with Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Belimumab is being evaluated in a Phase 2 trial for relapsed chronic lymphocytic leukemia conducted by University Hospital Tuebingen; the study is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Chronic Lymphoid Leukemia in Relapse | Phase 2 | Status: ACTIVE_NOT_RECRUITING